首页 > 最新文献

Medicina Clinica最新文献

英文 中文
Hiker's feet and myocarditis: An unusual presentation of anti-PM/Scl myopathy. 徒步旅行者的脚和心肌炎:抗PM/Scl肌病的一种不寻常表现。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-18 DOI: 10.1016/j.medcli.2024.07.024
Andrea Fernández-Valmaña, Andrea María Balado-González, Carlos Feijoo-Massó
{"title":"Hiker's feet and myocarditis: An unusual presentation of anti-PM/Scl myopathy.","authors":"Andrea Fernández-Valmaña, Andrea María Balado-González, Carlos Feijoo-Massó","doi":"10.1016/j.medcli.2024.07.024","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.07.024","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction model of hepatocellular carcinoma development in chronic hepatitis B virus infection in Spanish cohort. 西班牙队列中慢性乙型肝炎病毒感染者发生肝细胞癌的预测模型。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-17 DOI: 10.1016/j.medcli.2024.07.022
Paula Gavilán, Juan-Carlos Gavilán, Rocío Arnedo, Encarnación Clavijo, Isabel Viciana, José-Antonio González-Correa

Introduction and objectives: To identify risk factors associated with the development of hepatocellular carcinoma (HCC) in an unselected cohort of patients with chronic B virus infection (CHB) in Spain. A predictive model was developed to assess the risk of HCC.

Material and methods: A prospective open-cohort study recruited 446 unselected patients with chronic hepatitis B infection from two hospitals in Málaga (Spain). The follow-up time ranged from 0.5 to 31.5 years (mean: 13.8; SD: 9.5; median: 11.4 years). We used a Cox proportional hazard model to estimate the multivariable-adjusted hazard ratios of risk factors associated with the development of liver cancer and developed a clinical score, (HCCB score) to determine the risk of liver cancer, that categories patients into two risk levels for the development of HCC. We compared the diagnostic accuracy of our model with other previously published.

Results: During the follow-up period, 4.80% of the patients developed liver cancer (21 out of 437), 0.33 cases per 100 patient-years. Multivariate Cox regression analysis revealed that age >45 years, male gender, hepatitis C coinfection, alkaline phosphatase >147IU/L, Child score >5 points, glucose >126mg/dL, and a viral load >4.3 log10 IU/mL were independent risk factors. A risk score has been developed with a high predictive capacity for identifying patients at high risk of developing hepatocellular carcinoma. AUROC 0.87 (95% CI: 0.79-0.95).

Conclusions: An HCCB score greater than 5.42 points identifies a subgroup of chronic hepatitis B patients at high risk of developing liver cancer, who could benefit from screening measures for the early diagnosis of HCC.

引言和目的:在西班牙未经筛选的慢性乙型肝炎病毒感染(CHB)患者队列中确定与肝细胞癌(HCC)发生相关的风险因素。建立一个预测模型来评估发生 HCC 的风险:一项前瞻性开放队列研究从马拉加(西班牙)的两家医院招募了 446 名未经筛选的慢性乙型肝炎感染患者。随访时间从 0.5 年到 31.5 年不等(平均:13.8 年;标清:9.5 年;中位数:11.4 年)。我们使用 Cox 比例危险模型估算了与肝癌发展相关的风险因素的多变量调整危险比,并制定了一个临床评分(HCCB 评分)来确定肝癌风险,该评分将患者分为两个 HCC 发展风险等级。我们比较了我们的模型与之前发表的其他模型的诊断准确性:在随访期间,4.80%的患者(437 人中有 21 人)罹患肝癌,每 100 患者年中有 0.33 例。多变量 Cox 回归分析显示,年龄大于 45 岁、男性、丙型肝炎合并感染、碱性磷酸酶大于 147IU/L、Child 评分大于 5 分、血糖大于 126mg/dL、病毒载量大于 4.3 log10 IU/mL 是独立的风险因素。目前已开发出一种风险评分,对识别肝细胞癌高风险患者具有很高的预测能力。AUROC为0.87(95% CI:0.79-0.95):结论:HCCB 评分大于 5.42 分可确定慢性乙型肝炎患者中患肝癌风险较高的一个亚群,这些患者可受益于早期诊断 HCC 的筛查措施。
{"title":"Prediction model of hepatocellular carcinoma development in chronic hepatitis B virus infection in Spanish cohort.","authors":"Paula Gavilán, Juan-Carlos Gavilán, Rocío Arnedo, Encarnación Clavijo, Isabel Viciana, José-Antonio González-Correa","doi":"10.1016/j.medcli.2024.07.022","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.07.022","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>To identify risk factors associated with the development of hepatocellular carcinoma (HCC) in an unselected cohort of patients with chronic B virus infection (CHB) in Spain. A predictive model was developed to assess the risk of HCC.</p><p><strong>Material and methods: </strong>A prospective open-cohort study recruited 446 unselected patients with chronic hepatitis B infection from two hospitals in Málaga (Spain). The follow-up time ranged from 0.5 to 31.5 years (mean: 13.8; SD: 9.5; median: 11.4 years). We used a Cox proportional hazard model to estimate the multivariable-adjusted hazard ratios of risk factors associated with the development of liver cancer and developed a clinical score, (HCCB score) to determine the risk of liver cancer, that categories patients into two risk levels for the development of HCC. We compared the diagnostic accuracy of our model with other previously published.</p><p><strong>Results: </strong>During the follow-up period, 4.80% of the patients developed liver cancer (21 out of 437), 0.33 cases per 100 patient-years. Multivariate Cox regression analysis revealed that age >45 years, male gender, hepatitis C coinfection, alkaline phosphatase >147IU/L, Child score >5 points, glucose >126mg/dL, and a viral load >4.3 log<sub>10</sub> IU/mL were independent risk factors. A risk score has been developed with a high predictive capacity for identifying patients at high risk of developing hepatocellular carcinoma. AUROC 0.87 (95% CI: 0.79-0.95).</p><p><strong>Conclusions: </strong>An HCCB score greater than 5.42 points identifies a subgroup of chronic hepatitis B patients at high risk of developing liver cancer, who could benefit from screening measures for the early diagnosis of HCC.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The threat of dengue in Spain. 登革热在西班牙的威胁。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-17 DOI: 10.1016/j.medcli.2024.08.005
José-Manuel Ramos-Rincón, Ángel Giménez-Richarte
{"title":"The threat of dengue in Spain.","authors":"José-Manuel Ramos-Rincón, Ángel Giménez-Richarte","doi":"10.1016/j.medcli.2024.08.005","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.08.005","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hereditary salt-wasting tubulopathy associated with SLC12A3 mutation: Description of a case of Gitelman Syndrome. 与 SLC12A3 基因突变有关的遗传性盐耗竭性肾小管病:描述一例吉特曼综合征。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-17 DOI: 10.1016/j.medcli.2024.08.010
Antonio Bustos-Merlo, Antonio Rosales-Castillo, Pedro Alberto Alarcón-Blanco
{"title":"Hereditary salt-wasting tubulopathy associated with SLC12A3 mutation: Description of a case of Gitelman Syndrome.","authors":"Antonio Bustos-Merlo, Antonio Rosales-Castillo, Pedro Alberto Alarcón-Blanco","doi":"10.1016/j.medcli.2024.08.010","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.08.010","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac amyloidosis and red flags: natural history and its impact in morbimortality. 心脏淀粉样变性和红旗:自然史及其对死亡率的影响。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-16 DOI: 10.1016/j.medcli.2024.08.006
Emilio Blanco-López, Jorge Martínez-Del Río, Alba López-Calles, Martín Negreira-Caamaño, Daniel Águila-Gordo, Pablo Soto-Martín, Maria Maeve Soto-Pérez, Andrez Felipe Cubides-Novoa, Maria Gonzalez-Barderas, Ignacio Sánchez-Pérez, Jesús Piqueras-Flores

Introduction and objectives: Red flags (RF) are typical cardiac and extracardiac manifestations that may precede the definitive diagnosis of cardiac amiloidosis (CA) by several years, playing a pivotal role in the early diagnosis of the disease. The principal aim of the research was to determine the chronology of onset of RF throughout the natural history of CA as well as its prognostic influence.

Patients and methods: Observational, retrospective inquiry of consecutive patients with a definitive diagnosis of CA in a terciary hospital centre in Ciudad Real (Spain) between February 2016 and December 2023. We defined 21 RF and 3 adverse clinical events, establishing the date of occurrence of each of them.

Results: 102 patients (81.6±7.7 years; 84,3% males) with a diagnosis of CA (89.2% TTR; 10,8% AL) were included. The prevalence of RF was very high (8.4±2.3). In the natural history, the first to appear were integumentary, with the most specific cardiological ones being the closest to diagnosis. The 2-year mortality was 49%, with biomarker RFs and the presence of ≥10 RFs being associated with higher mortality.

Conclusions: RFs proved highly prevalent among patients with CA and substantially preceded disease diagnosis. RF burden was associated with prognosis in the follow-up of ATTR patients.

导言和目的:红旗(RF)是典型的心脏和心外表现,可能比心脏蛛网膜病(CA)的明确诊断早数年,在疾病的早期诊断中起着关键作用。研究的主要目的是确定 RF 在整个 CA 自然史中的发病时间顺序及其对预后的影响:对2016年2月至2023年12月期间在雷阿尔城(西班牙)一家三甲医院中心明确诊断为CA的连续患者进行观察性、回顾性调查。我们定义了 21 个 RF 和 3 个不良临床事件,并确定了每个事件的发生日期:共纳入 102 名诊断为 CA(89.2% TTR;10.8% AL)的患者(81.6±7.7 岁;84.3% 男性)。RF的发病率非常高(8.4±2.3)。在自然病史中,最先出现的是全身性疾病,而最接近诊断的是最特殊的心脏病。2年死亡率为49%,生物标志物RFs和RFs≥10个与死亡率较高有关:结论:RFs在CA患者中非常普遍,而且在疾病诊断前就已存在。在对ATTR患者的随访中,RF负荷与预后相关。
{"title":"Cardiac amyloidosis and red flags: natural history and its impact in morbimortality.","authors":"Emilio Blanco-López, Jorge Martínez-Del Río, Alba López-Calles, Martín Negreira-Caamaño, Daniel Águila-Gordo, Pablo Soto-Martín, Maria Maeve Soto-Pérez, Andrez Felipe Cubides-Novoa, Maria Gonzalez-Barderas, Ignacio Sánchez-Pérez, Jesús Piqueras-Flores","doi":"10.1016/j.medcli.2024.08.006","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.08.006","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Red flags (RF) are typical cardiac and extracardiac manifestations that may precede the definitive diagnosis of cardiac amiloidosis (CA) by several years, playing a pivotal role in the early diagnosis of the disease. The principal aim of the research was to determine the chronology of onset of RF throughout the natural history of CA as well as its prognostic influence.</p><p><strong>Patients and methods: </strong>Observational, retrospective inquiry of consecutive patients with a definitive diagnosis of CA in a terciary hospital centre in Ciudad Real (Spain) between February 2016 and December 2023. We defined 21 RF and 3 adverse clinical events, establishing the date of occurrence of each of them.</p><p><strong>Results: </strong>102 patients (81.6±7.7 years; 84,3% males) with a diagnosis of CA (89.2% TTR; 10,8% AL) were included. The prevalence of RF was very high (8.4±2.3). In the natural history, the first to appear were integumentary, with the most specific cardiological ones being the closest to diagnosis. The 2-year mortality was 49%, with biomarker RFs and the presence of ≥10 RFs being associated with higher mortality.</p><p><strong>Conclusions: </strong>RFs proved highly prevalent among patients with CA and substantially preceded disease diagnosis. RF burden was associated with prognosis in the follow-up of ATTR patients.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mesenteric panniculitis: A comprehensive description of a rare disease. 肠系膜泛发炎:对一种罕见疾病的全面描述。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-16 DOI: 10.1016/j.medcli.2024.08.001
Ningning Yang, Xiaoyun Ding

Mesenteric panniculitis (MP) is a rare disease characterized by chronic inflammation and fibrosis of the mesenteric adipose tissue. It is a benign disease that is influenced by many factors, mainly abdominal trauma and surgery. At present, the pathogenesis and clinical characteristics of MP are still not clear. Most patients with MP are asymptomatic, few will present gastrointestinal symptoms, especially abdominal pain. The diagnosis of MP mainly relies on imaging, such as CT. Medicine treatment is unnecessary for asymptomatic patients, and the curative effect of glucocorticoids is effective in patients with symptom. In the absence of severe intestinal obstruction, surgical treatment should not be considered. The purpose of this paper is to systematically introduce and summarize the epidemiology, etiology, histopathology, clinical manifestations, diagnosis, treatment and prognosis of MP, so as to improve the understanding of this disease.

肠系膜泛炎(MP)是一种以肠系膜脂肪组织慢性炎症和纤维化为特征的罕见疾病。它是一种良性疾病,受多种因素影响,主要是腹部创伤和手术。目前,MP 的发病机制和临床特征尚不明确。大多数 MP 患者无症状,少数会出现胃肠道症状,尤其是腹痛。MP 的诊断主要依靠 CT 等影像学检查。无症状患者无需药物治疗,糖皮质激素的疗效对有症状的患者有效。在没有严重肠梗阻的情况下,不应考虑手术治疗。本文旨在系统介绍和总结 MP 的流行病学、病因学、组织病理学、临床表现、诊断、治疗和预后,以提高对该病的认识。
{"title":"Mesenteric panniculitis: A comprehensive description of a rare disease.","authors":"Ningning Yang, Xiaoyun Ding","doi":"10.1016/j.medcli.2024.08.001","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.08.001","url":null,"abstract":"<p><p>Mesenteric panniculitis (MP) is a rare disease characterized by chronic inflammation and fibrosis of the mesenteric adipose tissue. It is a benign disease that is influenced by many factors, mainly abdominal trauma and surgery. At present, the pathogenesis and clinical characteristics of MP are still not clear. Most patients with MP are asymptomatic, few will present gastrointestinal symptoms, especially abdominal pain. The diagnosis of MP mainly relies on imaging, such as CT. Medicine treatment is unnecessary for asymptomatic patients, and the curative effect of glucocorticoids is effective in patients with symptom. In the absence of severe intestinal obstruction, surgical treatment should not be considered. The purpose of this paper is to systematically introduce and summarize the epidemiology, etiology, histopathology, clinical manifestations, diagnosis, treatment and prognosis of MP, so as to improve the understanding of this disease.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis. 药物引起的低钠血症和可能的相关信号:对向西班牙药物警戒系统报告的 659 个病例的分析和比例失调分析。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-16 DOI: 10.1016/j.medcli.2024.07.021
Lucía Estévez Asensio, Montserrat García, Zoraida Verde Rello, Verónica Velasco-González, Ana M Fernández-Araque, María Sainz-Gil
<p><strong>Introduction: </strong>Hyponatraemia has negative effects on cognitive function and gait stability and is a risk factor for osteoporosis, falls, fractures and hospital mortality. Acute hyponatraemia can lead to neurological dysfunction due to cerebral oedema. Its rapid correction can also be fatal, leading to osmotic demyelination syndrome. For some antiepileptics, thiazides, benzodiazepines or antidepressants this reaction is widely described. Knowing which drugs are most likely to cause hyponatraemia will allow early detection and prevention of its complications, as well as individualising the prescription of these drugs according to the patient's characteristics.</p><p><strong>Objective: </strong>The main objectives are to identify potential new safety signals related to hyponatraemia and to analyse the cases of hyponatraemia reported to the Spanish Pharmacovigilance System for Medicines for Human Use (SEFV-H).</p><p><strong>Method: </strong>A disproportionality and a descriptive analysis of individual case safety reports (ICSR) was performed in the SEFV-H database (FEDRA).</p><p><strong>Results: </strong>Six hundred and fifty-nine cases of suspected drug-induced hyponatraemia were found (0.6% of the total database). Over the 5 years period studied, there was a 57% increase in the number of hyponatraemia reports in Spain. Most of the reported cases were serious (93%). Patients were most often women (63.7%) and elderly (71.9%). The time to onset ranged from 1 to 7030 days (median, 79 days) and approximately 70% of the total occurred within the first year of treatment. Five hundred and forty-six patients (82.9%) showed complete recovery after the withdrawal of the suspected medicine. Diuretics (reported in 57.7% of the cases), antidepressants (in 25%), drugs acting on renin angiotensin system (in 24%) and antiepileptics (in 20.2%) were the most frequent involved drugs. Disproportionate reporting has been found for almost all the substances most frequently reported, higher for amiloride and oxcarbazepine. Regarding new safety signals, the Reporting Odds Ratio (ROR) (95% CI) was found to be statistically significant for valsartan [7.7 (5.1-11.5)], olmesartan [7.3 (4.7-11.1)], amlodipine [3.4 (2.1-5.4)], pregabalin [2.5 (1.4-4.5)], irbesartan [18.6 (9.6-35.9)], paliperidone [2.7 (1.3-5.7)], ritonavir [2.4 (1.1-5.5)], atosiban [29.7 (8.6-102.2)], melphalan [9.7 (3.5-26.8)] and clozapine [4.4 (1.6-11.8)]. These active ingredients do not include this reaction on their SPC and comply with the EMA criteria for a safety signals.</p><p><strong>Conclusion: </strong>There are increasing reports of drug-induced hyponatraemia. It can be serious and seems to most often affect women over 65 years of age who take more than 1 medication. The time to onset varies and can be very long, so patient monitoring should be continuous throughout treatment. Hydrochlorothiazide is the drug with the highest number of reported cases in our setting. In terms of disp
简介低钠血症对认知功能和步态稳定性有负面影响,是骨质疏松症、跌倒、骨折和住院死亡率的危险因素。急性低钠血症可因脑水肿导致神经功能障碍。快速纠正低钠血症也可能导致致命的渗透性脱髓鞘综合征。对于某些抗癫痫药、噻嗪类药物、苯二氮卓类药物或抗抑郁药,这种反应已被广泛描述。了解哪些药物最有可能导致低钠血症,就能及早发现和预防其并发症,并根据病人的特点个性化处方这些药物:主要目的是识别与低钠血症相关的潜在新安全信号,并分析向西班牙人用药品药物警戒系统(SEFV-H)报告的低钠血症病例:方法:在 SEFV-H 数据库 (FEDRA) 中对单个病例安全报告 (ICSR) 进行比例失调和描述性分析:结果:共发现 659 例疑似药物诱发的低钠血症病例(占数据库总数的 0.6%)。在研究的 5 年间,西班牙的低钠血症报告数量增加了 57%。大多数报告病例都很严重(93%)。患者多为女性(63.7%)和老年人(71.9%)。发病时间从 1 到 7030 天不等(中位数为 79 天),约 70% 的病例发生在治疗的第一年内。546 名患者(82.9%)在停用可疑药物后完全康复。最常涉及的药物有:利尿剂(占 57.7%)、抗抑郁药(占 25%)、作用于肾素血管紧张素系统的药物(占 24%)和抗癫痫药(占 20.2%)。几乎所有最常报告的药物都存在报告比例失调的情况,其中阿米洛利和奥卡西平的报告比例较高。关于新的安全信号,发现缬沙坦[7.7(5.1-11.5)]、奥美沙坦[7.3(4.7-11.1)]、氨氯地平[3.4(2.1-5.4)]、普瑞巴林[2.5(1.4-4.5)]、厄贝沙坦[18.6(9.6-35.9)]、帕利哌酮[2.7(1.3-5.7)]、利托那韦[2.4(1.1-5.5)]、阿托西班[29.7(8.6-102.2)]、美沙拉秦[9.7(3.5-26.8)]和氯氮平[4.4(1.6-11.8)]。这些活性成分的 SPC 中未包含这种反应,符合 EMA 安全信号的标准:结论:有关药物诱发低钠血症的报告越来越多。结论:有关药物诱发低钠血症的报告越来越多,这种情况可能很严重,而且似乎最常影响服用一种以上药物的 65 岁以上女性。发病时间各不相同,可能很长,因此在整个治疗过程中应持续监测患者。在我们的病例中,氢氯噻嗪是报告病例数最多的药物。在报告比例失调方面,利尿剂居首位,其次是奥卡西平和艾司卡西平等抗癫痫药。有几种药物出现了安全信号,其中普瑞巴林和帕利哌酮的安全信号更为可信,因此这些药物与低钠血症/SIAD 之间可能存在关联。必须进一步研究这一信号。同时,医护人员应注意这种可能性。报告疑似不良反应对于了解药品上市后的相关风险至关重要。
{"title":"Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis.","authors":"Lucía Estévez Asensio, Montserrat García, Zoraida Verde Rello, Verónica Velasco-González, Ana M Fernández-Araque, María Sainz-Gil","doi":"10.1016/j.medcli.2024.07.021","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.07.021","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Hyponatraemia has negative effects on cognitive function and gait stability and is a risk factor for osteoporosis, falls, fractures and hospital mortality. Acute hyponatraemia can lead to neurological dysfunction due to cerebral oedema. Its rapid correction can also be fatal, leading to osmotic demyelination syndrome. For some antiepileptics, thiazides, benzodiazepines or antidepressants this reaction is widely described. Knowing which drugs are most likely to cause hyponatraemia will allow early detection and prevention of its complications, as well as individualising the prescription of these drugs according to the patient's characteristics.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;The main objectives are to identify potential new safety signals related to hyponatraemia and to analyse the cases of hyponatraemia reported to the Spanish Pharmacovigilance System for Medicines for Human Use (SEFV-H).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Method: &lt;/strong&gt;A disproportionality and a descriptive analysis of individual case safety reports (ICSR) was performed in the SEFV-H database (FEDRA).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Six hundred and fifty-nine cases of suspected drug-induced hyponatraemia were found (0.6% of the total database). Over the 5 years period studied, there was a 57% increase in the number of hyponatraemia reports in Spain. Most of the reported cases were serious (93%). Patients were most often women (63.7%) and elderly (71.9%). The time to onset ranged from 1 to 7030 days (median, 79 days) and approximately 70% of the total occurred within the first year of treatment. Five hundred and forty-six patients (82.9%) showed complete recovery after the withdrawal of the suspected medicine. Diuretics (reported in 57.7% of the cases), antidepressants (in 25%), drugs acting on renin angiotensin system (in 24%) and antiepileptics (in 20.2%) were the most frequent involved drugs. Disproportionate reporting has been found for almost all the substances most frequently reported, higher for amiloride and oxcarbazepine. Regarding new safety signals, the Reporting Odds Ratio (ROR) (95% CI) was found to be statistically significant for valsartan [7.7 (5.1-11.5)], olmesartan [7.3 (4.7-11.1)], amlodipine [3.4 (2.1-5.4)], pregabalin [2.5 (1.4-4.5)], irbesartan [18.6 (9.6-35.9)], paliperidone [2.7 (1.3-5.7)], ritonavir [2.4 (1.1-5.5)], atosiban [29.7 (8.6-102.2)], melphalan [9.7 (3.5-26.8)] and clozapine [4.4 (1.6-11.8)]. These active ingredients do not include this reaction on their SPC and comply with the EMA criteria for a safety signals.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;There are increasing reports of drug-induced hyponatraemia. It can be serious and seems to most often affect women over 65 years of age who take more than 1 medication. The time to onset varies and can be very long, so patient monitoring should be continuous throughout treatment. Hydrochlorothiazide is the drug with the highest number of reported cases in our setting. In terms of disp","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenotype of severe tricuspid regurgitation induced by intracardiac pacing devices. 心内起搏装置诱发严重三尖瓣反流的表型。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-15 DOI: 10.1016/j.medcli.2024.08.002
Jose Alberto de Agustín, Orlando Figueroa, Carmen Olmos Blanco, Eduardo Pozo Osinalde, Patricia Mahia Casado, María Luaces, María Rivadeneira, Pedro Marcos-Alberca, Jose Juan Gómez de Diego, Luis Collado Yurrita, Antonio Fernández-Ortiz, Julián Villacastín

Introduction and aims: Tricuspid regurgitation (TR) induced by the implantation of cardiac implantable electronic devices (CIED) is an increasingly common cause of severe TR. Our aim was to describe the echocardiographic phenotypic characteristics of CIED-induced severe TR.

Methods: Retrospective cohort study that included patients with severe TR related to CIED diagnosed in the cardiac imaging unit of a Spanish tertiary hospital.

Results: 37 patients with severe TR induced by lead/electrode interference formed our study group. TR was predominantly severe (68%), followed by massive (21%) and torrential (11%). The leaflet most affected by the interference was the septal. 58% of the sample presented severe dilatation of the right atrium (RA) (mean RA area 28cm2). Mean tricuspid annulus measurement was 42mm. The usual parameters for quantifying RV systolic function were on average within the normal range (TAPSE mean 19mm, S' wave 10mm, FAC 41%), while global RV strain (RVGLS -15%) and free wall strain (RVFWLS -19%) were found reduced. An incipient degree of ventricular/pulmonary arterial uncoupling was evident (mean TAPSE/PSAP 0.34, SGLVD/PSAP 0.27%/mmHg).

Conclusions: Our patients with CIED-induced severe TR are characterized by a heterogeneous phenotype with a high prevalence of severe RA and tricuspid annulus dilatation. RVGLS, RVFWLS, and arterial ventricular coupling were the most sensitive parameters for early assessment of RV systolic dysfunction.

导言和目的:植入心脏植入式电子装置(CIED)引起的三尖瓣反流(TR)是导致严重TR的一个日益常见的原因。我们的目的是描述 CIED 引起的严重 TR 的超声心动图表型特征:方法:回顾性队列研究,纳入西班牙一家三甲医院心脏影像科诊断的与 CIED 相关的严重 TR 患者:37名因导联/电极干扰而诱发严重TR的患者组成了我们的研究小组。TR以重度为主(68%),其次是大面积(21%)和暴发性(11%)。受干扰影响最大的是室间隔心叶。58%的样本显示右心房(RA)严重扩张(RA平均面积为28平方厘米)。三尖瓣环的平均测量值为 42 毫米。量化左心室收缩功能的常规参数平均在正常范围内(TAPSE平均值19毫米,S波10毫米,FAC 41%),而整体左心室应变(RVGLS -15%)和游离壁应变(RVFWLS -19%)均有所降低。心室/肺动脉未耦合的初期程度明显(平均TAPSE/PSAP为0.34,SGLVD/PSAP为0.27%/mmHg):结论:CIED诱导的重度TR患者具有异质性表型,重度RA和三尖瓣环扩张的发生率较高。RVGLS、RVFWLS和动脉心室耦合是早期评估RV收缩功能障碍最敏感的参数。
{"title":"Phenotype of severe tricuspid regurgitation induced by intracardiac pacing devices.","authors":"Jose Alberto de Agustín, Orlando Figueroa, Carmen Olmos Blanco, Eduardo Pozo Osinalde, Patricia Mahia Casado, María Luaces, María Rivadeneira, Pedro Marcos-Alberca, Jose Juan Gómez de Diego, Luis Collado Yurrita, Antonio Fernández-Ortiz, Julián Villacastín","doi":"10.1016/j.medcli.2024.08.002","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.08.002","url":null,"abstract":"<p><strong>Introduction and aims: </strong>Tricuspid regurgitation (TR) induced by the implantation of cardiac implantable electronic devices (CIED) is an increasingly common cause of severe TR. Our aim was to describe the echocardiographic phenotypic characteristics of CIED-induced severe TR.</p><p><strong>Methods: </strong>Retrospective cohort study that included patients with severe TR related to CIED diagnosed in the cardiac imaging unit of a Spanish tertiary hospital.</p><p><strong>Results: </strong>37 patients with severe TR induced by lead/electrode interference formed our study group. TR was predominantly severe (68%), followed by massive (21%) and torrential (11%). The leaflet most affected by the interference was the septal. 58% of the sample presented severe dilatation of the right atrium (RA) (mean RA area 28cm<sup>2</sup>). Mean tricuspid annulus measurement was 42mm. The usual parameters for quantifying RV systolic function were on average within the normal range (TAPSE mean 19mm, S' wave 10mm, FAC 41%), while global RV strain (RVGLS -15%) and free wall strain (RVFWLS -19%) were found reduced. An incipient degree of ventricular/pulmonary arterial uncoupling was evident (mean TAPSE/PSAP 0.34, SGLVD/PSAP 0.27%/mmHg).</p><p><strong>Conclusions: </strong>Our patients with CIED-induced severe TR are characterized by a heterogeneous phenotype with a high prevalence of severe RA and tricuspid annulus dilatation. RVGLS, RVFWLS, and arterial ventricular coupling were the most sensitive parameters for early assessment of RV systolic dysfunction.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine effectiveness in patients admitted for influenza during the 2023-2024 season. 2023-2024 年流感季节因流感入院的患者接种疫苗的效果。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-15 DOI: 10.1016/j.medcli.2024.07.023
Christian Ruzafa Martinez, Salvador Valero, Eva García Villalba, Cristina Tomás, Ángeles Muñoz, Antonia Alcaraz, Rodrigo Martínez-Rodríguez, María Dolores Hernández, María Isabel Martínez, María Rosario Vicente, Elena Guijarro Westermeyer, Román González Hipólito, Enrique Bernal

Background and goal: Vaccination against influenza is widespread worldwide, reducing complications associated with infection. However, the impact of vaccination on mortality/ICU admission in hospitalized patients has been little studied.

Material and methods: A retrospective observational study was conducted on 238 patients hospitalized for influenza from October 2023 to January 2024 to evaluate the vaccine's effectiveness in terms of the combined event of ICU admission/mortality during hospitalization. Additionally, the characteristics of vaccinated patients and the existence of bacterial superinfection were analyzed. Cox regression was performed using the SPSS program and the free «R» software.

Results: A total of 238 patients were included. Those vaccinated were older (78.2±8.8 vs 69.97±16.6years; P<.001) and were more likely to have hypertension (82.2% vs 56.2%; P<.001), cardiovascular disease (36.6% vs 24.1%; P=.05), chronic bronchopathy (25.7% vs 8.8%; P=.001), or chronic kidney disease (22.8% vs 8.8%; P=0.005). They had lower levels of CRP (8.39±9.55 vs 11.03±10.75mg/dl; P=.05), procalcitonin (0.62±1.74 vs 1.67±4.57ng/dl; P=.05), and SOFA scores (1.13±0.9 vs 1.39±0.97; P=0.033). 11 patients were admitted to ICU (4.6%) and 11 died (4.6%). Influenza vaccination was associated as a protective factor against ICU admission/mortality in the Cox regression (HR=0.216; 95%CI: 0.062-0.759, P=.017). The presence of bacterial superinfection was similar between vaccinated and unvaccinated patients (63.4% vs 67.9%; P=.556).

Conclusions: Influenza vaccination may reduce the probability of ICU admission or death. This effect is likely due to better control of the immune response. We did not observe any relationship with the risk of presenting bacterial superinfection.

背景和目标:流感疫苗接种已在全球普及,可减少与感染相关的并发症。然而,接种疫苗对住院患者死亡率/入住重症监护室的影响却鲜有研究:对 2023 年 10 月至 2024 年 1 月期间因流感住院的 238 名患者进行了一项回顾性观察研究,以评估疫苗对住院期间入住重症监护室/死亡的综合影响。此外,还分析了接种疫苗患者的特征和是否存在细菌超级感染。使用 SPSS 程序和免费的 "R "软件进行了 Cox 回归:结果:共纳入 238 名患者。接种者年龄较大(78.2±8.8 岁 vs 69.97±16.6岁;PC结论:接种流感疫苗可降低入住 ICU 或死亡的概率。这种效应可能是由于更好地控制了免疫反应。我们没有发现接种疫苗与出现细菌超级感染的风险有任何关系。
{"title":"Vaccine effectiveness in patients admitted for influenza during the 2023-2024 season.","authors":"Christian Ruzafa Martinez, Salvador Valero, Eva García Villalba, Cristina Tomás, Ángeles Muñoz, Antonia Alcaraz, Rodrigo Martínez-Rodríguez, María Dolores Hernández, María Isabel Martínez, María Rosario Vicente, Elena Guijarro Westermeyer, Román González Hipólito, Enrique Bernal","doi":"10.1016/j.medcli.2024.07.023","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.07.023","url":null,"abstract":"<p><strong>Background and goal: </strong>Vaccination against influenza is widespread worldwide, reducing complications associated with infection. However, the impact of vaccination on mortality/ICU admission in hospitalized patients has been little studied.</p><p><strong>Material and methods: </strong>A retrospective observational study was conducted on 238 patients hospitalized for influenza from October 2023 to January 2024 to evaluate the vaccine's effectiveness in terms of the combined event of ICU admission/mortality during hospitalization. Additionally, the characteristics of vaccinated patients and the existence of bacterial superinfection were analyzed. Cox regression was performed using the SPSS program and the free «R» software.</p><p><strong>Results: </strong>A total of 238 patients were included. Those vaccinated were older (78.2±8.8 vs 69.97±16.6years; P<.001) and were more likely to have hypertension (82.2% vs 56.2%; P<.001), cardiovascular disease (36.6% vs 24.1%; P=.05), chronic bronchopathy (25.7% vs 8.8%; P=.001), or chronic kidney disease (22.8% vs 8.8%; P=0.005). They had lower levels of CRP (8.39±9.55 vs 11.03±10.75mg/dl; P=.05), procalcitonin (0.62±1.74 vs 1.67±4.57ng/dl; P=.05), and SOFA scores (1.13±0.9 vs 1.39±0.97; P=0.033). 11 patients were admitted to ICU (4.6%) and 11 died (4.6%). Influenza vaccination was associated as a protective factor against ICU admission/mortality in the Cox regression (HR=0.216; 95%CI: 0.062-0.759, P=.017). The presence of bacterial superinfection was similar between vaccinated and unvaccinated patients (63.4% vs 67.9%; P=.556).</p><p><strong>Conclusions: </strong>Influenza vaccination may reduce the probability of ICU admission or death. This effect is likely due to better control of the immune response. We did not observe any relationship with the risk of presenting bacterial superinfection.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vertical nystagmus due to Chiari malformation type I. 奇拉氏畸形 I 型导致的垂直性眼球震颤。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-15 DOI: 10.1016/j.medcli.2024.07.017
María José Abenza Abildúa, Vanesa Lores Gutiérrez, Javier Giner García
{"title":"Vertical nystagmus due to Chiari malformation type I.","authors":"María José Abenza Abildúa, Vanesa Lores Gutiérrez, Javier Giner García","doi":"10.1016/j.medcli.2024.07.017","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.07.017","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142469877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicina Clinica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1